Stoke Therapeutics Stock Falls 5% Despite Improved Earnings In Q4

(RTTNews) - Stoke Therapeutics, Inc. (STOK) is trading at $8.53, down 5.22 percent or $0.47 during Tuesday's trading, after reporting fourth-quarter results. Revenue for the quarter was $22.6 million, higher than the $2.8 million reported in the prior year.

The stock opened at $8.63 and has traded between $7.70 and $8.73 so far, compared to a previous close of $9.00 on the Nasdaq. Trading volume stands at 533,878 shares, below the average volume of 805,508. The stock's 52-week range is $5.60 to $17.58.

Moreover, the company posted a net loss of $10.5 million, or $0.18 per share, an improvement from a $27.0 million net loss, or $0.60 per share, in the same period of 2023.